CMMB

Chemomab Therapeutics Ltd (NASDAQ:CMMB) My long position on this small bio play remains intact. On the technical side, the stock has been pulling back on low volume to test the breakout zone around the $20 area. If this zone is respected next week, I expect that the next rebound will push the price up to $27. Money flow has been very solid over the past days and the accumulation/distribution continues to be bullish, we just might be on our way to higher prices. NOTE: The company has a poster presentation scheduled for Wednesday at the International Liver Congress 2021 (EASL). Analysts' price target range consensus $43